4
Changes in Ownership
Transcode Therapeutics, Inc. Filed Acc 0001104659-22-073636
Options or other derivatives
- Director acquired 9,500 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Calais Philippe Director | 2022-06-22 | Grant or award · Stock Option (Right to Buy) | +9,500 | 9,500 | D | ||
Loading xslF345X03/tm2219203d3_4seq1.xml…